Litigation Details for Onyx Therapeutics, Inc. v. Breckenridge Pharmaceutical Inc. (D. Del. 2016)
✉ Email this page to a colleague
Onyx Therapeutics, Inc. v. Breckenridge Pharmaceutical Inc. (D. Del. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-10-27 |
| Court | District Court, D. Delaware | Date Terminated | 2019-05-16 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Patents | 7,232,818; 7,417,042; 7,491,704; 7,737,112; 8,129,346; 8,207,125; 8,207,126; 8,207,127; 8,207,297 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Onyx Therapeutics, Inc. v. Breckenridge Pharmaceutical Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Onyx Therapeutics, Inc. v. Breckenridge Pharmaceutical Inc. (D. Del. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2016-10-27 | 1 | 12. United States Patent No. 7,232,818 (the “’818 Patent”), entitled “Compounds For Enzyme Inhibition…Product prior to the expiration of U.S. Patent Nos. 7,417,042; 7,232,818; 7,491,704; 7,737,112; 8,129,346;… COUNT II: INFRINGEMENT OF U.S. PATENT NO. 7,232,818 48. Plaintiff hereby realleges… THE PATENTS-IN-SUIT 11. United States Patent No. 7,417,042 (the “’042 Patent”), entitled… This is a civil action for patent infringement under the patent laws of the United States, Title | External link to document | |
| 2019-05-16 | 25 | ~Util - Terminate Civil Case | enjoined from infringing United States Patent Numbers 7,417,042, 7,737,112, and 8,207,125, on its own … 2016 16 May 2019 1:16-cv-01001 830 Patent None District Court, D. Delaware | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
